A Novel Druggable Epigenetic Vulnerability Pathway in Hepatocellular Carcinoma (HCC)

Grant

Date/time Interval

  • June 1, 2019 - March 31, 2023
  • Total Award Amount

  • 188262.00
  • Direct Costs

  • 126776.00
  • Sponsor Award Id

  • OSP2018062
  • Contributor

  • Wajapeyee, Narendra   Principal Investigator